About us

Launched in 2012 by the Gut Microbiota and Health section of the European Society for Neurogastroenterology and Motility (ESNM), the “Gut Microbiota for Health” platform’s mission is to share knowledge and promote debate regarding gut microbiota. Our goal is to raise awareness and interest on the gut’s bacterial community and its importance for our health and quality of life both among the scientific and medical community and society in general.

With more than 85,000 members around the globe, our platform has become an international benchmark for gut microbiota information and debate. We encourage contributions and interactions from readers and followers via our website and social media channels (Facebook, Twitter @GMFHx, Twitter @GutmicrobiotaWWYoutube, and LinkedIn).

Visit our website and subscribe to our newsletters to stay up-to-date with the latest news about the amazing world of gut microbiota.

Gut Microbiota News Watch is a section on the Gut Microbiota for Health platform dedicated to expanding knowledge about gut microbiota’s importance for health and quality of life among the media and society in general. Using clear and easy-to-understand language, our aim is to keep our readers up-to-date on the latest facts and news about gut microbiota. We publish content in English, French and Spanish. Interviews with experts, videos, book reviews and discussions about recent findings from leading international research bodies are just part of what you can find in our section. The content we share on our site is sent to our subscribers via our monthly Gut Microbiota for Health News Watch Newsletter (also available in 3 languages). You can subscribe on our homepage.

Gut Microbiota Research & Practice is a section of the Gut Microbiota for Health platform dedicated to promoting knowledge-sharing and debate among researchers, scientists and healthcare professionals. It offers a selection of discussions about articles from scientific literature as well as other content including interviews with experts, event reports, e-learning activities and special publications. The new content we publish is sent to our subscribers via our bimonthly Gut Microbiota for Health Research & Practice Newsletter. You can subscribe on our homepage.

Meet our Board of Experts


Joël DoréResearch Director at the French National Research Institute for Agriculture, Food and the Environment, INRAE, Dr. Joël Doré is currently President of the Executive Committee of the Pre-Industrial Demonstrator MetaGenoPolis, a platform of excellence dedicated to quantitative and functional metagenomics, funded by the French government Futures Investments. He is Deputy Head of the MICALIS institute “Food and Gut Microbiology for Human Health” and scientific board member of Microbiology Pole of the Doctoral School “Therapeutic Innovations” at Paris-XI University. Joël Doré received his PhD from the University of Illinois at Urbana-Champaign, USA, in 1988. His main research interest is the molecular assessment of the human intestinal microbiota in health and disease and metagenomic investigation of the molecular cross-talk between intestinal bacteria and human cells. Dr. Doré has published >120 publications in peer reviewed scientific journals. His goal is to provide a better understanding of the intestinal ecosystem in order to support therapeutic choices in the medical area, as well as health claims for functional foods.

United States of America

Mary Ellen SandersMary Ellen Sanders is a consultant in the area of probiotic microbiology, with special expertise on paths to scientific substantiation of probiotic product label claims. Dr. Sanders served as the founding president of the International Scientific Association for Probiotics and Prebiotics (www.isappscience.org) and is currently the organization’s Director of Scientific Affairs/ Executive Officer. This international, non-profit association of academic and industrial scientists is dedicated to advancing the science of probiotics and prebiotics. Through numerous written, oral and video pieces, including a website, www.usprobiotics.org, she strives to provide objective, evidence-based information on probiotics for consumers and professionals. Key activities include: Panels to determine GRAS status of probiotic strains ; member of the American Gastroenterological Association Scientific Advisory Board for AGA Center for Gut Microbiome Research and Education ; World Gastroenterology Organisation Committee preparing practice guidelines for the use of probiotics and prebiotics for GI indications (2008, 2011, 2014) ; working group convened by the FAO/WHO that developed guidelines for probiotics (2002).


Premysl BercikDr. Bercik obtained an MD degree from Charles University, Prague, Czechoslovakia. He then pursued post-graduate doctoral studies at the University of Lausanne, Switzerland, where he investigated neural control of gastrointestinal motility. He trained as a postdoctoral research and clinical fellow at McMaster University under the supervision of Prof. Stephen Collins focusing on animal models of functional gastrointestinal diseases. Currently, he is Associate Professor in the Division of Gastroenterology, Director of the Clinical Motility laboratory and member of the Farncombe Family Digestive Health Research Institute at McMaster University, Canada. His clinical interest lies in functional bowel disorders, intestinal dysmotility, gastroparesis and celiac disease. His basic research focuses on the role of intestinal bacteria in gut-brain axis in the context of gut function, low-grade inflammation and behavior, including anxiety and depression. Dr. Bercik has published more than 50 publications in peer reviewed scientific journals.


Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS) and WELBIO investigator. He is leading a team at the Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research lab from the UCLouvain, Brussels, Belgium. After a B.Sc. degree in dietetics he joined the Faculty of Medicine of UCLouvain where he received a M.Sc. in Nutrition, another M.Sc. in health Sciences, and a PhD in Biomedical Sciences (physiology and metabolism). Read more


Elena VerdúDr. Verdu’s research has focused on the pathophysiology of inflammatory and functional gastrointestinal disorders. She undertook clinical research training at the University of Lausanne, Switzerland, where she studied the interaction between chronic infection with Helicobacter pylori and gastritis in humans and the possible therapeutic role of probiotic bacteria. Her PhD studies in the Institute of Microbiology and Gnotobiology at the Czech Academy of Science and University of Lausanne focused on the effect of bacterial antigens in animal models of inflammatory bowel disease. As a post-doctoral fellow at McMaster University she gained experience with animal models of gut functional diseases and investigated the mechanisms of action of probiotic bacteria. As a member of the Farncombe Family Digestive Health Research Institute at McMaster University, Dr. Verdu investigates host-microbial and dietary interactions in the context of celiac disease, irritable bowel syndrome and inflammatory bowel disease. She has been honored with the New Investigator Award (Canadian Celiac Association), the New Investigator Award (Functional Gut-Brain Research Group, USA) and the Campbell Research Award in celiac disease (Canadian Celiac Association). The American Gastroenterology Association and the Canadian Association of Gastroenterology have awarded her the “Master’s in Gastroenterology Award” for basic science and “Young Investigator’s Award”, respectively. She is Associate Professor at the Division of Gastroenterology, Dep. of Medicine at McMaster University and currently directs the Axenic Gnotobiotic Unit at McMaster.

United States of America

James VersalovicDr. James Versalovic received his M.D. with Honors at Baylor College of Medicine (BCM) in 1995 and his Ph.D. in Cellular and Molecular Biology at BCM in 1994. He pursued clinical pathology/medical microbiology residency training at the Massachusetts General Hospital and Harvard Medical School. He also received postdoctoral research training in the Division of Comparative Medicine at the Massachusetts Institute of Technology (MIT). Dr. Versalovic joined the medical staff as a clinical pathologist at the Massachusetts General Hospital and served as Assistant Professor of Pathology at Harvard Medical School from 1999-2001. He is board-certified in clinical pathology, molecular genetic pathology, and molecular diagnostics. Dr. Versalovic currently serves as Pathologist-In-Chief, Head of the Department of Pathology, and as member of the Board of Directors at Texas Children’s Hospital. He also serves as Vice Chair of Molecular Pathology and Omics at BCM, and Director of the Texas Children’s Microbiome Center. He holds the Milton J. Finegold endowed chair as Professor of Pathology & Immunology, and Professor of Pediatrics, Molecular and Human Genetics, and Molecular Virology & Microbiology at Baylor College of Medicine. He is Co-Director of the Medical Scientist (MD/PhD) Training Program at Baylor. He served as Editor-in-Chief of the Manual of Clinical Microbiology and Editor of Therapeutic Microbiology: Probiotics and Related Strategies. As a Principal Investigator, his primary research interests include the human microbiome, probiotics, medical and molecular microbiology, innate immunity, digestive diseases, and gastrointestinal physiology. His research program has been supported by the U.S. National Institutes of Health, Department of Defense, and Crohn’s and Colitis Foundation of America. Dr. Versalovic has authored 131 primary manuscripts, 34 book chapters, and 2 patents. He received the Lansky Award as a national leader in pathology under the age of 45 from the College of American Pathologists Foundation. He also received the BioGaia Ivan Casas Probiotics Research Award and the BCM Graduate School of Biomedical Sciences Distinguished Alumnus Award.

Stéphane Schneider


Stéphane SchneiderProfessor Stéphane Schneider heads the Nutritional Support Unit in the Gastroenterology and Nutrition Department Archet University Hospital in Nice (France). He is also head of the Nice University Hospital’s food-nutrition liaison committee. Dr. Schneider is vice-president of the French-Speaking Society for Clinical Nutrition and Metabolism (SFNEP), and former chair of the Educational and Clinical Practice Committee of the European Society for Clinical Nutrition and Metabolism (ESPEN). Three years after receiving his M.D. in Gastroenterology from the University of Nice Sophia-Antipolis, he became an assistant Professor and later a full Professor of Nutrition. He is also certified by the European Board of Gastroenterology and Hepatology. He obtained a Master of Science from the University of Paris VII, and a Ph.D. in nutrition from the University Paul Cezanne, as well as a CME Diploma from Harvard Medical School. His main research interests are intestinal failure and the effects of aging and chronic diseases on nutritional status. He has published 188 articles in peer-reviewed scientific journals, with an h index of 37. His goal is to help understand better the role of the intestinal ecosystem, as well as the effects of different forms of bacteriotherapy, in digestive and non-digestive disorders featuring dysbiosis.

Hervé M. Blottière


Hervé M. BlottièreResearch Director at INRA, the French National Research Institute for Agricultural and Food Research, Hervé Blottière presently heads a research laboratory studying the Human Intestinal Ecosystem within the MICALIS institute “Food and Gut Microbiology for Human Health”. He is Scientific Director of the MetaGenoPolis initiative, a platform of excellence dedicated to quantitative and functional metagenomics, funded by the French government Futures Investments, where he has set up a robotic platform to allow high throughput screenings. He is also involved in ANR, the French National Research Agency, and the EU funded projects on Human Gut Microbiota and Health: MetaHIT, Cross-Talk and MetaCardis. Hervé Blottière obtained a PhD in Tumor Immunology from the University of Nantes (France) in 1989, and spent two years at the Wistar Institute (Philadelphia, U.S.A.). His main research interest is the Functional Metagenomics approach to study host-microbiota cross-talk. He has published >135 publications in peer reviewed scientific journals. His goal is to provide a better understanding of the symbiosis between gut microbiota and its host and to decipher the mechanisms of interaction between intestinal bacteria and human mucosal cells at the molecular level. Finding these molecular mediators will provide target for manipulation or therapeutics tools to restore symbiosis in chronic diseases.

Meet our Publishing Team

Editorial Head – Netherland

René van den Wijngaard undertook his PhD-training at the Academic Medical Center/University of Amsterdam (The Netherlands). His thesis focused on autoimmune destruction of melanocytes in vitiligonous skin. He next changed to gut-oriented research at the Department of Gastroenterology and Hepatology in the same institute. At present, he is a scientific staff member in this department and carries out his research activities at the Tytgat Institute for Liver and Intestinal Research. His focus is on the role of mast cells and gut fungi/yeast in abdominal pain complaints of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).

Editor – Spain

Cristina Saez is a freelance science journalist. She works for several media, for instance the Spanish newspaper La Vanguardia, where she coordinates the science section, Big Vang; as well as research centres and scientific societies. She has been awarded for her journalistic work, among others, with the Boehringer Ingelheim Award in Medical Journalism 2015. Follow Cristina on Twitter @saez_cristina

Editor – Spain

Allison Clark has a master in nutrition and health from Open University in Barcelona and a master in journalism. She is a freelance writer and nutritionist and has written various peer review papers about the role the gut microbiota plays in health, disease and endurance exercise performance. Allison is passionate about the role diet and the gut microbiota play in health and disease. Follow her on Twitter @Heal_your_Gut

Editor – Canada

Manon Oliero is starting her PhD about gut microbiota, nutrition and cancer at the CRCHUM of Montreal. Before, she specialized in the gut microbiota and nutrition field by obtaining a master’s degree in Paris in microbiology and a food and health engineer degree in Beauvais. She first meets the scientific communication world in Barcelona after her work on gut microbiota and diet at the VHIR. She is really concern about health of the population and believe that with a better diet and lifestyle we can all make ourselves healthier.

Megan Mouw

Editor – Canada

Megan MouwMegan Mouw holds a Bachelor of Science in microbiology from McGill University (Canada). Driven by her experiences at UCSF medical center in San Francisco, Megan is passionate about the role that the gut microbiota plays in maintaining health and wellness. She is currently perusing graduate studies in Microbiology and Environmental Toxicology at the University of California Santa Cruz and hopes to share her love of science through writing.

With the support of